Bupropion Press Articles
Market Wire - Exclusive: President and CEO of IntelGenX Discusses the Firm's Pending FDA Decision
Posted by admin / Under BupropionNovember 7, 2011 --
In an exclusive interview, Horst G. Zerbe, Ph.D., President and CEO of IntelGenX Corporation (OTCBB: IGXT) shares his thoughts on the firm's...
Published on Sunday 5th of February 2012 02:43:47 AM
Read more...
Chain Drug Review - Top 20 generic drugs by U.S. sales
Posted by admin / Under BupropionAugust 29, 2011 --
Top 20 Generic Drugs by U.S. SalesRank Product 2010 dollar sales (mil.)1 Pantoprazole Sodium...
Published on Sunday 5th of February 2012 02:43:47 AM
Read more...
Market Wire - IntelGenx Announces Successful Pre-Approval Inspection of its Lead Product CPI-300
Posted by admin / Under BupropionAugust 2, 2011 --
IntelGenx Corp. (TSX VENTURE:IGX)(OTCBB:IGXT) ("IntelGenx") today announced that Pillar5 Pharma Inc. ("Pillar5") successfully passed a...
Published on Sunday 5th of February 2012 02:43:47 AM
Read more...
Journal of Family Practice - Q/ Which smoking cessation interventions work best?
Posted by admin / Under BupropionJuly 1, 2011 --
EVIDENCE-BASED ANSWER
A/ NICOTINE REPLACEMENT THERAPY (NRT), bupropion, nortriptyline, clonidine, and varenicline are all effective,...
Published on Sunday 5th of February 2012 02:43:47 AM
Read more...
Market Wire - IntelGenx Announces New PDUFA Date for Its Single Dose 450 mg Bupropion Hydrochloride Tablet
Posted by admin / Under BupropionJune 14, 2011 --
IntelGenx Corp. (TSX VENTURE: IGX)(OTCBB: IGXT) ("IntelGenx", or "the Company"), announced that the U.S. Food and Drug Administration ("FDA")...
Published on Sunday 5th of February 2012 02:43:47 AM
Read more...
